Epoetin Alfa in Cancer Patients: Evidence-Based Guidelines

This publication has 21 references indexed in Scilit:

• Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
  British Journal of Cancer, 1999
• A Canadian Survey of Cancer Patients’ Experiences
  Journal of Pain and Symptom Management, 1998
• Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy
  Medical Oncology, 1998
• Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
  Journal of Pain and Symptom Management, 1997
• Prevention of chemotherapy‐induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double‐blind, randomized, phase III study)
  Transfusion, 1996
• Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin
  European Journal Of Cancer, 1993
• The Frequency of Red Cell Transfusion for Anemia in Patients Receiving Chemotherapy A Retrospective Cohort Study
  American Journal of Clinical Oncology, 1993
• Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
  The International Journal of Cell Cloning, 1991
• The significance of anemia in clinical radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1986
• MEASUREMENT OF PAIN
  Published by Elsevier ,1974